PREVIEW
When British surgeon Norman Barrett first identified the metaplastic columnar epithelium of the esophagus that bears his name, the condition was considered an oddity that was probably of little significance. Now, half a century later, Barrett's esophagus is recognized as the most serious complication of gastroesophageal reflux disease (GERD) and a precursor of esophageal adenocarcinoma. Primary care physicians often face concerns about how to manage patients with long-standing GERD who could be at risk for cancer. In this article, Dr Gopal reviews the incidence of Barrett's esophagus, current screening recommendations, surveillance guidelines, prevention strategies, and management options for patients found to have the condition.